New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
Baylor College of Medicine4y
Adenovirus Vectors
This cassette is then transferred to the adenovirus vector plasmid (pAdeno X, Clontech Laboratories or pAd5F35, The Journal of Gene Medicine Volume 6, Issue 6 , Pages 631 - 641). The adenovirus vector ...
EurekAlert!1d
Nasal COVID-19 vaccine based on WashU technology to enter US clinical trials
The adenovirus carries the SARS-CoV-2 protein into the nose ... vaccine and subsequently infected did not pass the virus on to others, breaking the cycle of transmission. “All effective vaccines ...